What is the ideal operational and business model for research sites to be highly efficient and financially sustainable?
The answer: It depends!
Do we buy, build, or partner to be successful? Innovative approaches have been developed and will continue to evolve, but, what do these models look like and what are the benefits and possible limitations associated with them?
Models may include partnership models, network models (exclusive and non-exclusive), alignment with an academic medical center, integrated health delivery network, independent sites….or other configurations.
Learn about different models of clinical trial service delivery from our panel of experts and how they are achieving operational excellence and financial stability.
Objectives:
- Compare/contrast varying models of clinical trial services delivery (Academic/Independent Site|Network|Partnership|Other).
- Describe best practices that are transferrable to other entities.
- Identify key performance indicators supporting best practices.
Leigh Boehmer - Chief Medical Officer - Association of Community Cancer Centers
Ryan Jones - CEO - Florence Healthcare
Rachel Karlnoski - Executive Director of Clinical Research Operations - University of South Florida & Tampa General Hospital
Curry Luttrell - Executive Director - OneOncology
Lindsay McCarthy - VP Site Network - WCG
